Lichterfeld M - Search Results

1

Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy.

Lichterfeld M, Nischalke HD, Bergmann F, Wiesel W, Rieke A, Theisen A, Fätkenheuer G, Oette M, Carls H, Fenske S, Nadler M, Knechten H, Wasmuth JC, Rockstroh JK. Lichterfeld M, et al. HIV Med. 2002 Jan;3(1):37-43. doi: 10.1046/j.1464-2662.2001.00091.x. HIV Med. 2002. PMID: 12059949 Free article. Clinical Trial.

2

Decreased prevalence of Helicobacter pylori infection in HIV patients with AIDS defining diseases.

Lichterfeld M, Lorenz C, Nischalke HD, Scheurlen C, Sauerbruch T, Rockstroh JK. Lichterfeld M, et al. Z Gastroenterol. 2002 Jan;40(1):11-4. doi: 10.1055/s-2002-19637. Z Gastroenterol. 2002. PMID: 11803495

3

Antiretroviral drug toxicity -- a challenge for the hepatologist?

Spengler U, Lichterfeld M, Rockstroh JK. Spengler U, et al. Among authors: lichterfeld m. J Hepatol. 2002 Feb;36(2):283-94. doi: 10.1016/s0168-8278(01)00311-7. J Hepatol. 2002. PMID: 11830343 Review. No abstract available.

4

Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.

Lichterfeld M, Leifeld L, Nischalke HD, Rockstroh JK, Hess L, Sauerbruch T, Spengler U. Lichterfeld M, et al. J Infect Dis. 2002 Jun 15;185(12):1803-7. doi: 10.1086/340829. Epub 2002 May 20. J Infect Dis. 2002. PMID: 12085329

5

Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients.

Rockstroh JK, Mudar M, Lichterfeld M, Nischalke HD, Klausen G, Gölz J, Dupke S, Notheis G, Stein L, Mauss S; German Clinical AIDS Working group (KAAD). Rockstroh JK, et al. Among authors: lichterfeld m. AIDS. 2002 Oct 18;16(15):2083-5. doi: 10.1097/00002030-200210180-00016. AIDS. 2002. PMID: 12370510

6

[Fatty liver and increased serum lactate in a woman with HIV].

Lichterfeld M, Fischer HP, Spengler U, Rockstroh JK. Lichterfeld M, et al. Dtsch Med Wochenschr. 2003 Jan 17;128(3):81-4. doi: 10.1055/s-2003-36654. Dtsch Med Wochenschr. 2003. PMID: 12529837 German.

7

Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy.

Lichterfeld M, Wöhrmann A, Schmeisser N, Fätkenheuer G, Salzberger B, Wyen C, Schmitz K, Sauerbruch T, Rockstroh JK. Lichterfeld M, et al. Eur J Med Res. 2003 Feb 21;8(2):56-60. Eur J Med Res. 2003. PMID: 12626282 Clinical Trial.

8

[Antiretroviral treatment of HIV infected patients].

Lichterfeld M, Rockstroh JK. Lichterfeld M, et al. Med Monatsschr Pharm. 2003 Apr;26(4):111-21; quiz 121-2. Med Monatsschr Pharm. 2003. PMID: 12722525 Review. German. No abstract available.

9

The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS.

Lichterfeld M, Nischalke HD, van Lunzen J, Söhne J, Schmeisser N, Woitas R, Sauerbruch T, Rockstroh JK, Spengler U. Lichterfeld M, et al. Clin Immunol. 2003 Apr;107(1):55-9. doi: 10.1016/s1521-6616(02)00050-5. Clin Immunol. 2003. PMID: 12738250

10

Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by lightcycler real-time polymerase chain reaction.

Nischalke HD, Nattermann J, Lichterfeld M, Woitas RP, Rockstroh JK, Sauerbruch T, Spengler U. Nischalke HD, et al. Among authors: lichterfeld m. AIDS Res Hum Retroviruses. 2004 Jul;20(7):750-4. doi: 10.1089/0889222041524634. AIDS Res Hum Retroviruses. 2004. PMID: 15307921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters